TriGemX Bio
Latest round
- Series D
Last raised
- Feb 2022
Total raised
- $463M
Investors
- 15
About TriGemX Bio
, formerly known as Kallyope Inc.Kallyope Inc. is dedicated to advancing therapeutic solutions for complex health issues. Founded in 2015 in New York, US, the company has engaged in 7 investment deals to date.00 mn.Kallyope Inc. focuses on innovative therapeutic solutions for neurological and metabolic diseases, leveraging its proprietary Klarity™ platform. This platform integrates a diverse array of technologies to facilitate the identification and development of novel therapeutics aimed at addressing significant health challenges. The company's primary offerings are centered around discovering differentiated pharmaceuticals that target the underlying mechanisms of complex diseases. Kallyope serves a wide range of stakeholders in the healthcare ecosystem, including pharmaceutical companies, researchers, and healthcare providers, who benefit from the advancements in medication development.Kallyope's revenue structure is based on collaborations and partnerships with various entities in the pharmaceutical and biotechnology industries. These collaborations facilitate the advancement of Kallyope's therapeutic candidates while providing a financial framework for ongoing research initiatives. While specific pricing plans and transaction structures are not disclosed, it is presumed that the business transactions involve B2B partnerships, focusing on joint development agreements and licensing arrangements with established firms in the healthcare sector. Kallyope's flagship offerings, developed through its Klarity™ platform, position the company favorably within a competitive market for neurological and metabolic therapies.
Who invested in TriGemX Bio
15 investors across 6 rounds
See all investors in TriGemX Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TriGemX Bio
Who invested in TriGemX Bio?
TriGemX Bio has 15 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TriGemX Bio raised?
TriGemX Bio has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did TriGemX Bio last raise money?
TriGemX Bio's most recent round on record is a Series D, in Feb 2022.
What does TriGemX Bio do?
, formerly known as Kallyope Inc.
Where is TriGemX Bio headquartered?
TriGemX Bio is headquartered in New York, US.
Which VCs invest in companies like TriGemX Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TriGemX Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like TriGemX Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.